Two Randomized Trials of Low-Dose Calcium Supplementation in Pregnancy

医学 相对风险 随机对照试验 置信区间 怀孕 子痫前期 坦桑尼亚 入射(几何) 产科 活产 内科学 遗传学 环境科学 物理 环境规划 光学 生物
作者
Pratibha Dwarkanath,Alfa Muhihi,Christopher R. Sudfeld,Blair J. Wylie,Molin Wang,Nandita Perumal,Tinku Thomas,Shabani Kinyogoli,Mohamed Bakari,Ryan Fernandez,John-Michael Raj,Ndeniria Swai,Nirmala Buggi,R Shobha,Mary M. Sando,Christopher Duggan,Honorati Masanja,Anura V. Kurpad,Andrea B. Pembe,Wafaie Fawzi
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:390 (2): 143-153 被引量:13
标识
DOI:10.1056/nejmoa2307212
摘要

BackgroundThe World Health Organization recommends 1500 to 2000 mg of calcium daily as supplementation, divided into three doses, for pregnant persons in populations with low dietary calcium intake in order to reduce the risk of preeclampsia. The complexity of the dosing scheme, however, has led to implementation barriers.MethodsWe conducted two independent randomized trials of calcium supplementation, in India and Tanzania, to assess the noninferiority of a 500-mg daily dose to a 1500-mg daily dose of calcium supplementation. In each trial, the two primary outcomes were preeclampsia and preterm birth, and the noninferiority margins for the relative risks were 1.54 and 1.16, respectively.ResultsA total of 11,000 nulliparous pregnant women were included in each trial. The cumulative incidence of preeclampsia was 3.0% in the 500-mg group and 3.6% in the 1500-mg group in the India trial (relative risk, 0.84; 95% confidence interval [CI], 0.68 to 1.03) and 3.0% and 2.7%, respectively, in the Tanzania trial (relative risk, 1.10; 95% CI, 0.88 to 1.36) — findings consistent with the noninferiority of the lower dose in both trials. The percentage of live births that were preterm was 11.4% in the 500-mg group and 12.8% in the 1500-mg group in the India trial (relative risk, 0.89; 95% CI, 0.80 to 0.98), which was within the noninferiority margin of 1.16; in the Tanzania trial, the respective percentages were 10.4% and 9.7% (relative risk, 1.07; 95% CI, 0.95 to 1.21), which exceeded the noninferiority margin.ConclusionsIn these two trials, low-dose calcium supplementation was noninferior to high-dose calcium supplementation with respect to the risk of preeclampsia. It was noninferior with respect to the risk of preterm live birth in the trial in India but not in the trial in Tanzania. (Funded by the Bill and Melinda Gates Foundation and others; ClinicalTrials.gov number, NCT03350516; Clinical Trials Registry–India number, CTRI/2018/02/012119; and Tanzania Medicines and Medical Devices Authority Trials Registry number, TFDA0018/CTR/0010/5).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
谜记完成签到,获得积分10
1秒前
共享精神应助Cheung2121采纳,获得30
1秒前
光撒盐完成签到,获得积分10
2秒前
cowboy007完成签到,获得积分10
2秒前
张振宇完成签到 ,获得积分10
3秒前
zz发布了新的文献求助10
4秒前
zzq778发布了新的文献求助10
6秒前
黄怡婷完成签到 ,获得积分10
6秒前
Daisy应助科研通管家采纳,获得10
7秒前
机智苗应助科研通管家采纳,获得10
7秒前
香蕉觅云应助科研通管家采纳,获得10
7秒前
FashionBoy应助科研通管家采纳,获得10
7秒前
赘婿应助科研通管家采纳,获得10
7秒前
大模型应助科研通管家采纳,获得10
7秒前
yanmu2010应助科研通管家采纳,获得10
7秒前
kingwill应助科研通管家采纳,获得20
8秒前
银包铜应助科研通管家采纳,获得10
8秒前
共享精神应助科研通管家采纳,获得10
8秒前
8秒前
情怀应助科研通管家采纳,获得10
8秒前
李爱国应助科研通管家采纳,获得10
8秒前
所所应助科研通管家采纳,获得10
8秒前
8秒前
Orange应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
Lucas完成签到,获得积分10
10秒前
C胖胖完成签到,获得积分10
10秒前
舒心的完成签到,获得积分10
10秒前
zz完成签到,获得积分10
11秒前
12秒前
12秒前
12秒前
13秒前
luozejun完成签到,获得积分10
13秒前
ycp完成签到,获得积分10
14秒前
dawang完成签到 ,获得积分10
14秒前
洁净的智宸完成签到 ,获得积分10
14秒前
zhaopeipei发布了新的文献求助10
14秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029